Sleep apnea syndrome in patients with cerebrovascular disease

Sleep apnea syndrome in patients with cerebrovascular disease - Cerebrovascular disease and sleep apnea syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003411

Enrollment

800

Registered

2010-04-20

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular disease

Interventions

The patients with sleep apnea syndrome BiPAP treatment during sleep

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cerebrovascular disease patinents within 24 hour of onst

Exclusion criteria

Exclusion criteria: patients with poor respiratory status

Design outcomes

Primary

Measure	Time frame
The presence of sleep apnea syndrome and associated factor in acute phase (from onset to 7days) of cerebrovascular disease. Short or long-term (at discharge and two years after) prognosis after treatment for sleep apnea syndrome	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026